Annual Update in Intensive Care and Emergency Medicine 2018 / / edited by Jean-Louis Vincent |
Edizione | [1st ed. 2018.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
Descrizione fisica | 1 online resource (675 pages) |
Disciplina | 616.025 |
Collana | Annual Update in Intensive Care and Emergency Medicine |
Soggetto topico |
Critical care medicine
Emergency medicine Internal medicine Intensive / Critical Care Medicine Emergency Medicine Internal Medicine |
ISBN | 3-319-73670-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I. Sepsis: underlying mechanisms -- Part II. Antimicrobial issues -- Part III. Cardiovascular concerns -- Part IV. Cardiovascular resuscitation -- Part V. Respiratory support -- Part VI. Monitoring: new aspects -- Part VII. Acute renal failure -- Part VIII. Renal replacement therapy.- Part IX. Fluid administration -- Part X. Coagulopathy and blood products -- Part XI. Acute cerebral concerns -- Part XII. Therapeutic issues -- Part XIII. Moving the patient -- Part XIV. The future -- Index. |
Record Nr. | UNINA-9910300267303321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Annual Update in Intensive Care and Emergency Medicine 2019 / / edited by Jean-Louis Vincent |
Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
Descrizione fisica | 1 online resource (653 pages) |
Disciplina | 616.025 |
Collana | Annual Update in Intensive Care and Emergency Medicine |
Soggetto topico |
Critical care medicine
Emergency medicine Internal medicine Intensive / Critical Care Medicine Emergency Medicine Internal Medicine |
ISBN | 3-030-06067-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I. Precision medicine -- Part II. Acute Respiratory Failure – ARDS -- Part III. Extracorporeal Respiratory Support -- Part IV. Cardiac arrest -- Part V. Cardiac Function -- Part VI. Shock -- Part VII. Hemodynamic Monitoring -- Part VIII. Intravenous Fluids -- Part IX. Altered Renal Function -- Part X. The Neurological Patient -- Part XI. Infection and Antibiotics -- Part XII. Sepsis -- Part XIII. Iron Metabolism -- Part XIV. Extremes of Age -- Part XV. Patient Comfort -- Part XVI. Medical Education. |
Record Nr. | UNINA-9910337524303321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Annual Update in Intensive Care and Emergency Medicine 2020 / / edited by Jean-Louis Vincent |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (659 pages) |
Disciplina | 616.028 |
Collana | Annual Update in Intensive Care and Emergency Medicine |
Soggetto topico |
Critical care medicine
Emergency medicine Internal medicine Intensive / Critical Care Medicine Emergency Medicine Internal Medicine Medicina intensiva Medicina d'urgència Medicina interna |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-37323-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I. Respiratory Issues -- Physiology of respiratory drive in ICU patients: implications for diagnosis and treatment.-Monitoring patient respiratory effort during mechanical ventilation: lung and diaphragm-protective ventilation -- Ten reasons to use mechanical power to guide ventilator settings in patients without ARDS -- Part II. ARDS -- Extracellular vesicles in ARDS: new insights into pathogenesis with novel clinical applications.-ARDS subphenotypes: understanding a heterogeneous syndrome -- Assessment of VILI risk during spontaneous breathing and assisted mechanical ventilation -- Part III. Biomarkers -- The future of ARDS biomarkers: where are the gaps in implementation of precision medicine? -- Utility of inflammatory biomarkers for predicting organ failure and outcomes in cardiac arrest patients -- Troponin elevations after cardiac surgery: just ‘troponitis’? -- Biomarkers of sepsis during continuous renal replacement therapy: have we found the appropriate biomarker to use in this situation? -- Part IV. Fluids -- Do intensivists need to care about the revised Starling principle? -- Right ventricular dysfunction and fluid administration in critically ill patients.-Intravenous fluids: don’t drown in confusion! -- Part V. Hemodynamic Management -- Update in right ventricular hemodynamic, echocardiographic and extra-cardiac ultrasound monitoring -- Management of hypotension: implications for non-cardiac surgery and the intensive care -- Heterogeneity of cardiovascular response to standardized sepsis resuscitation -- Part VI. The Microcirculation -- Clinical relevance of the endothelial glycocalyx in critically ill patients -- Customized monitoring of the microcirculation in patients with a left ventricular assist device -- Monitoring pf the sublingual microcirculation at the bedside: yes, it is possible and useful -- Microcirculation in patients with sepsis: from physiology to interventions -- Part VII. Sepsis -- Macrophage activation syndrome in sepsis: does it exist and how to recognize it? -- Is T cell exhaustion a treatable trait in sepsis? -- Cell-free hemoglobin: a new therapeutic target in sepsis? -- Therapeutic potential of the gut microbiota in the management of sepsis -- Part VIII. Bleeding & Transfusion -- Blood transfusion practice during extracorporeal membrane oxygenation: rationale and modern approaches to management -- The use of frozen platelets for the treatment of bleeding -- Viscoelastic assay-guided hemostatic therapy in perioperative and critical care.-Extracorporeal filter and circuit patency: a personalized approach to anticoagulation -- Part IX. Prehospital Intervention -- Prehospital resuscitation with low titer O+ whole blood by civilian EMS teams: rationale and evolving strategies for use -- Mobile stroke units: taking the emergency room to the patient -- Part X. Trauma -- Evaluating quality in trauma systems -- Vasopressors for post-traumatic hemorrhagic shock: friends or foes? -- Extracranial tsunami after traumatic brain injury -- Part XI. Neurological Aspects -- Ten false beliefs about mechanical ventilation in brain injured patients -- Manifestations of critical illness brain injury -- Essential non-invasive multimodality neuromonitoring for the critically ill patient -- Part XII. Organ Donation -- Brain death after cardiac arrest: pathophysiology, prevalence and potential for organ donation -- Organ recovery procedure in donation after controlled circulatory death with normothermic regional perfusion: state of the art -- Part XIII. Oncology -- Admitting adult critically ill patients with hematological malignancies to the ICU: a Sisyphean task or work in progress? -- Onco-nephrology: acute kidney injury in critically ill cancer patients -- Part XIV. Severe Complications -- A clinician’s guide to management of intraabdominal hypertension and abdominal compartment syndrome in critically ill patients -- Update on the management of iatrogenic gas embolism -- Alcohol withdrawal syndrome in the ICU: preventing rather than treating? -- Part XV. Prolonged Critical Illness -- Muscle dysfunction in critically ill children -- Respiratory muscle rehabilitation in patients with prolonged mechanical ventilation: a targeted approach -- Post-intensive care syndrome and chronic critical illness: a tale of two syndromes -- Part XVI. Organizational and Ethical Aspects -- Sepsis as organ and health system failure -- Burnout and joy in the profession of critical care medicine -- Advance directives in the United Kingdom: ethical, legal and practical considerations -- Part XVII. Future Aspects -- Mobile devices for hemodynamic monitoring -- Artificial intelligence in the intensive care unit -- Index. |
Record Nr. | UNINA-9910392737803321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Annual update in intensive care and emergency medicine 2021 / / Jean-Louis Vincent, editor |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (301 pages) |
Disciplina | 616.028 |
Collana | Annual Update in Intensive Care and Emergency Medicine |
Soggetto topico |
Critical care medicine
Emergency medicine Medicina intensiva Serveis d'urgències hospitalàries |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-73231-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910497086403321 |
Cham, Switzerland : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Annual update in intensive care and emergency medicine 2022 / / edited by Jean-Louis Vincent |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (398 pages) |
Disciplina | 616.028 |
Collana | Annual Update in Intensive Care and Emergency Medicine |
Soggetto topico |
Critical care medicine
Medicina intensiva Medicina d'urgència |
Soggetto genere / forma | Llibres electrònics |
ISBN |
9783030934330
9783030934323 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Contents -- Abbreviations -- Part I: Sepsis and the Immune Response -- 1: The Role of Mitochondria in the Immune Response in Critical Illness -- 1.1 Introduction -- 1.2 Mitochondrial Machinery That Mediates and Regulates Immune Responses in Critical Illness -- 1.2.1 Metabolic Reprogramming -- 1.2.2 Mitochondrial ROS and mtDNA -- 1.2.3 Succinate and Itaconate -- 1.2.4 Mitochondrial Dynamics -- 1.3 Immunometabolism: The Perfect World Scenario vs. the Critical Illness Scenario -- 1.4 Potential of Mitochondria-Targeting Therapy in Critical Care -- 1.5 Challenges of Applying Mitochondria-Targeting Therapy in Critical Care -- 1.6 Conclusion -- References -- 2: Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option? -- 2.1 Introduction -- 2.2 Immunopathogenesis of Sepsis -- 2.3 Immunopathogenesis of ARDS -- 2.4 Mechanisms of Action of Tetracyclines in ARDS -- 2.4.1 In Vivo Models -- 2.4.1.1 Effects on Inflammatory Cytokines and NLRP3 Inflammasome Caspase-1 Signaling -- 2.4.1.2 Effects on MMPs -- 2.4.1.3 Effects on Neutrophil Transmigration -- 2.4.2 Human Data -- 2.5 Mechanisms of Action of Tetracyclines in Sepsis -- 2.5.1 In Vitro Models -- 2.5.1.1 Effects on Cytokine and Chemokine Production -- 2.5.1.2 Effects on Arachidonic Acid Metabolites and NO Production -- 2.5.2 In Vivo Models -- 2.5.2.1 Effects on MAPK Signaling Pathways and Inflammatory Mediators -- 2.5.2.2 Effects on Organ Dysfunction -- 2.5.3 Human Data -- 2.6 Future Research Perspectives -- 2.7 Conclusion -- References -- 3: Hit Early: Blocking Interleukin-1 in the Treatment of COVID-19 Pneumonia -- 3.1 Introduction -- 3.2 Cytokines and Disease Progression in COVID-19 -- 3.3 Contribution of Monocytes and Macrophages in Early Cytokine Response -- 3.4 How Can Early Activation of IL-1 Be Identified?.
3.5 SAVE Strategy: Early Blockade of IL-1 Guided by Biomarkers -- 3.6 Conclusion -- References -- 4: Hemoadsorption Therapy During ECMO: Emerging Evidence -- 4.1 Introduction -- 4.2 Devices and Implementation -- 4.3 Hemoadsorption in Combination with ECMO -- 4.4 Hemoadsorption in Severe COVID-19 Supported with ECMO -- 4.5 Discussion and Outlook -- 4.6 Conclusion -- References -- Part II: Respiratory Issues -- 5: The Forgotten Circulation and Transpulmonary Pressure Gradients -- 5.1 Introduction -- 5.2 Pulmonary Vessel Anatomy -- 5.3 Pulmonary Vascular Dysfunction -- 5.4 Pulmonary Circulation and Its Components -- 5.4.1 The Transpulmonary Driving Pressure: A Small Gradient with Big Importance -- 5.4.2 Pulmonary Vascular Resistance and 'Closing Pressures' -- 5.5 Measuring the Transpulmonary Pressure Gradient -- 5.6 The Evolving Role of Pulmonary Arterial Compliance -- 5.7 Relevant Clinical Scenarios in Critical Illness -- 5.7.1 Pulmonary Hypertension -- 5.7.2 Right Ventricular Dysfunction -- 5.8 Can Right Ventricular-Pulmonary Arterial (RV-PA) Coupling Shed more Light on the RV-Pulmonary Circuit in Critical Illness? -- 5.9 Conclusion -- References -- 6: Oxygen: Origin, Physiology, Pathophysiology, and Use in the Critically Ill -- 6.1 Introduction -- 6.2 Origin of Oxygen in the Earth's Atmosphere -- 6.3 Measurements and Estimations of Oxygenation -- 6.4 Definition of Hypoxemia, Normoxemia, and Hyperoxemia -- 6.5 Physiology of Oxygen in Humans -- 6.6 Pathophysiology of Oxygen in Humans: Hypoxemia and Effects of Lack of O2 -- 6.7 Pathophysiology of Oxygen in Humans: Hyperoxia, Hyperoxemia, and O2 Toxicity -- 6.8 Effects of Normoxia, Hypoxia and Hyperoxia in Critically Ill Patients -- 6.9 Future Studies -- 6.10 Conclusion -- References -- 7: Nebulized Therapeutics for COVID-19 Pneumonia in Critical Care -- 7.1 Introduction. 7.2 Nebulized Therapeutics for COVID-19 Pneumonia -- 7.3 Technical Aspects of Nebulized Drug Therapy -- 7.4 Current Clinical Trials on Nebulized COVID-19 Therapeutics in Critical Care -- 7.4.1 Antivirals -- 7.4.1.1 Chloroquine/Hydroxychloroquine -- 7.4.1.2 Remdesivir -- 7.4.1.3 Ivermectin -- 7.4.2 Immunomodulators -- 7.4.2.1 Granulocyte-Monocyte Colony-Stimulating Factor (GM-CSF) -- 7.4.3 Anticoagulants -- 7.4.3.1 Heparin -- 7.4.4 Fibrinolytics -- 7.4.4.1 Tissue Plasminogen Activator (t-PA) -- 7.4.5 Anti-Inflammatory Agents -- 7.4.5.1 Interferon -- 7.4.5.2 Steroids -- 7.4.5.3 Retinoic Acid -- 7.4.6 Mucokinetics/Mucolytics -- 7.4.6.1 Dornase Alfa -- 7.4.7 Pulmonary Vasodilators -- 7.4.7.1 Epoprostenol, Iloprost -- 7.4.8 Miscellaneous -- 7.4.8.1 Surfactant -- 7.5 Barriers to Safe and Effective Nebulized Therapy in COVID-19 Pneumonia in Critical Care -- 7.6 Conclusion -- References -- Part III: Mechanical Ventilation -- 8: Positive End-Expiratory Pressure in Invasive and Non-invasive Ventilation of COVID-19 Acute Respiratory Distress Syndrome -- 8.1 Introduction -- 8.2 Evidence for a Unique CARDS Pathophysiology -- 8.3 A Computational Simulator to Compare CARDS Versus ARDS Pathophysiology -- 8.4 Setting PEEP in Invasive Mechanical Ventilation of CARDS Patients -- 8.5 Setting PEEP in Non-invasive Pressure Support Ventilation of CARDS Patients -- 8.6 Conclusion -- References -- 9: Personalized Mechanical Ventilation Settings: Slower Is Better! -- 9.1 Introduction -- 9.2 Strain, Stress, and Strain Rate: Insights from Polymeric Material -- 9.3 Origins of the Mechanical Power Formula: The Components Must Respect Time -- 9.4 Slow the Changes in Tidal Volume during Mechanical Ventilation -- 9.5 Slow the Changes in Respiratory Rate during Mechanical Ventilation -- 9.5.1 Prolonged Versus Short Inspiratory Time?. 9.5.2 High Versus Low Inspiratory Flow? -- 9.6 Stepwise Increase in Airway Pressure during Recruitment Maneuvers -- 9.7 Slow Decreases in PEEP Levels and Lung Damage -- 9.8 Smooth the Expiration Phase: Does It Matter? -- 9.9 Conclusion -- References -- 10: Spontaneous Breathing in Acute Respiratory Failure -- 10.1 Introduction -- 10.2 Acute Respiratory Distress Syndrome -- 10.3 Mechanical Ventilation and VILI -- 10.4 Stress, Strain, and Stress Raisers -- 10.5 P-SILI and Assisted Ventilation -- 10.6 Lung Mechanics and Pulmonary Heterogeneity -- 10.7 Conclusion -- References -- 11: Laryngeal Injury: Impact on Patients in the Acute and Chronic Phases -- 11.1 Introduction -- 11.2 Laryngeal Injury -- 11.2.1 Endotracheal Intubation -- 11.2.2 Identification and Management of Laryngeal Injury in the Acute Phase -- 11.3 Impact of Laryngeal Injury on the Patient in the Acute Phase -- 11.3.1 Swallowing and Return to Oral Intake -- 11.3.2 Communication in the ICU -- 11.4 Impact of Laryngeal Injury on the Patient in the Chronic Phase -- 11.5 Laryngeal Injury in the ICU and beyond -- 11.5.1 Clinical Assessment: Future Directions -- 11.5.2 Laryngeal Rehabilitation -- 11.5.3 Community Follow Up of Critical Illness Survivors -- 11.6 Conclusion -- References -- Part IV: Fluids and Electrolytes -- 12: Fluid Responsiveness as a Physiologic Endpoint to Improve Successful Weaning -- 12.1 Introduction -- 12.2 Weaning from Mechanical Ventilation -- 12.3 Weaning Failure -- 12.4 Weaning-Induced Pulmonary Edema -- 12.5 De-Resuscitation -- 12.6 Physiology-Based Fluid Depletion -- 12.7 Monitoring Fluid Responsiveness Prior to SBT -- 12.8 Conclusion -- References -- 13: Tidal Volume Challenge Test: Expanding Possibilities -- 13.1 Introduction -- 13.2 Rationale for Developing the Tidal Volume Challenge Test. 13.3 Reliability of the Tidal Volume Challenge Test to Predict Fluid Responsiveness -- 13.4 How to Perform and Interpret the Tidal Volume Challenge Test -- 13.5 Applications of the Tidal Volume Challenge Test -- 13.5.1 In ICU Patients Mechanically Ventilated Using Low Tidal Volumes -- 13.5.2 In Mechanically Ventilated Patients with Spontaneous Breathing Activity -- 13.5.3 In Patients with Normal Lungs Ventilated Using Low Tidal Volumes in the Operating Room -- 13.5.3.1 In the Supine Position -- 13.5.3.2 In the Prone Position -- 13.5.4 During Laparoscopic Surgery Using Pneumoperitoneum in the Trendelenburg Position -- 13.6 Comparison of Tidal Volume Challenge with Other Tests Used to Predict Fluid Responsiveness -- 13.7 Advantages of the Tidal Volume Challenge -- 13.8 Limitations of the Tidal Volume Challenge -- 13.9 Future Directions -- 13.10 Conclusion -- References -- 14: Fluid Management in COVID-19 ICU Patients -- 14.1 Introduction -- 14.2 Why Patients with COVID-19 Can Develop Acute Circulatory Failure? -- 14.2.1 Hypovolemia -- 14.2.2 Vasoplegia -- 14.2.3 Impaired Left Heart Function -- 14.2.4 Right Ventricular (RV) Dysfunction or Failure -- 14.3 Consequences of Fluid Therapy in COVID-19 Patients with Shock -- 14.4 How to Assess the Benefits and the Risks of Fluid Administration in COVID-19 Patients with Shock? -- 14.5 Summary -- 14.6 Conclusion -- References -- 15: Electrolytes in the ICU -- 15.1 Introduction -- 15.2 Physiology and Pathophysiology -- 15.2.1 Sodium: Regulator of Osmolality -- 15.2.1.1 Physiology -- 15.2.1.2 Pathophysiology -- 15.2.2 Potassium: Determinant of Excitability -- 15.2.2.1 Physiology -- 15.2.2.2 Pathophysiology -- 15.2.3 Magnesium: Membrane Stabilizer -- 15.2.3.1 Physiology -- 15.2.3.2 Pathophysiology -- 15.2.4 Calcium: Conduction and Contraction -- 15.2.4.1 Physiology. 15.2.4.2 Pathophysiology. |
Record Nr. | UNINA-9910558490303321 |
Cham, Switzerland : , : Springer, , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Annual update in intensive care and emergency medicine 2023 / / edited by Jean-Louis Vincent |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer Nature Switzerland AG, , [2023] |
Descrizione fisica | 1 online resource (540 pages) |
Disciplina | 616.028 |
Collana | Annual Update in Intensive Care and Emergency Medicine |
Soggetto topico |
Critical care medicine
Emergency medicine |
ISBN |
9783031230059
9783031230042 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I. Precision Medicine -- The role of transcriptomics in redefining critical illness -- Metagenomic sequencing in the ICU for precision diagnosis of critical infectious illnesses -- Risk stratification and precision medicine: is it feasible for severe infections? -- Interrogating the sepsis host immune response using cytomics -- Precision medicine in septic shock -- Part II. Sepsis Biomarkers And Organ Dysfunction Scores -- Host response biomarkers for sepsis In the emergency room -- Repetitive assessment of biomarker combinations as a new paradigm to detect sepsis early -- Organ dysfunction scores in the adult ICU -- Part III. ARDS -- Ex vivo lung perfusion models to explore the pathobiology of ARDS -- Interpretation of lung perfusion in ARDS -- A structured diagnostic algorithm for patients with ARDS -- Hemodynamic implications of prone positioning in patients with ARDS -- Part IV. Ventilatory Support -- Update on the management of acute respiratory failure using non-invasive ventilation and pulse oximetry -- Managing the physiologically difficult airway in critically ill adults -- Dyspnea in patients receiving invasive mechanical ventilation -- The potential risks of pressure support ventilation -- Advancing sedation strategies to improve clinical outcomes in ventilated critically ill patients -- Part V. Extracorporeal Support Setting and monitoring of mechanical ventilation during venovenous ECMO -- Early mobilization of patients receiving ECMO for respiratory failure -- Physiological adaptations during weaning from venovenous ECMO -- Novel strategies to enhance the efficiency of extracorporeal CO2 -- Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest: a systematic approach -- Temporary and durable mechanical circulatory support in the ICU -- Part VI. Fluids and Transfusion -- Venous congestion: why examine the abdomen with ultrasound in critically ill patients? -- The most important questions in the current practice of transfusion of critically bleeding patients -- Part VII. Acute Renal Failure -- Fluid management and acute kidney injury -- Cardiorenal syndrome 1: what’s in a name? -- Part VIII. The Microcirculation and Metabolism -- Update on the microcirculatory assessment of the critically ill patient -- Intracellular measurements of micronutrients in critically ill patients -- Optimal glycemic targets in critically ill patients with diabetes -- Part IX: A Look Back at COVID-19 -- Hydroxychloroquine: time for reappraisal of its effect in COVID-19 patients -- Blood purification in COVID-19 outside acute kidney injury -- Part X. Neurologic Considerations -- Epidemiology, outcomes and costs of pediatric traumatic brain injury patients treated in the ICU -- Quality improvements in the determination of death by neurologic criteria around the world -- Part XI. Obstetric Issues -- COVID-19-induced ARDS in pregnancy: implications for the non-COVID era -- Amniotic fluid embolism -- Part XII. Pre and Post-Intensive Care -- Remote telehealth aid during humanitarian crisis -- Boarding in the emergency department: challenges and success strategies to mitigate the current crisis -- Post-intensive care syndrome revisited in light of the COVID-19 pandemic -- Part XIII. Ethical Issues -- Rethinking the role of palliative care in the ICU. |
Record Nr. | UNINA-9910683343403321 |
Cham, Switzerland : , : Springer Nature Switzerland AG, , [2023] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Antibiotika bei Infektionen mit multiresistenten Erregern / / herausgegeben von Sebastian Schulz-Stübner, Frauke Mattner, Elisabeth Meyer, Rolf Mahlberg |
Edizione | [1st ed. 2016.] |
Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2016 |
Descrizione fisica | 1 online resource (160 p.) |
Disciplina | 610 |
Soggetto topico |
Infectious diseases
Pharmacotherapy Critical care medicine Surgery Infectious Diseases Intensive / Critical Care Medicine |
ISBN | 3-662-48060-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | ger |
Nota di contenuto | 1. Leitsätze der Antibiotikatherapie -- 2. Checkliste MRE-Infektionen -- 3. Generika - Handelsnamen -- 4. Handelsnamen - Generika.- 5. Einleitung -- 6. MRSA-Infektionen -- 7. VRE-Infektionen -- 8.Multiresistente gramnegative Bakterien -- 9 MDR-TB -- 10. Wichtige Substanzen.-. |
Record Nr. | UNINA-9910483972903321 |
Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Anticoagulation and Hemostasis in Neurosurgery / / edited by Christopher M. Loftus |
Edizione | [1st ed. 2016.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
Descrizione fisica | 1 online resource (XI, 404 p. 61 illus., 43 illus. in color.) |
Disciplina | 617.48 |
Soggetto topico |
Neurosurgery
Surgery Critical care medicine Emergency medicine Hematology Intensive / Critical Care Medicine Emergency Medicine |
ISBN | 3-319-27327-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part 1. General Principles -- Physiology of Hemostasis -- Laboratory Assessment of Physiologic and Pathologic Hemostasis -- Current Anticoagulation Drugs and Mechanisms of Action -- Reversal of Target-Specific Oral Anticoagulants -- Overview, Treatment, Measurement, and Modification of Platelet Function -- Role of Antiplatelet Therapy in Neurosurgery: Efficacy and Safety Profiles -- Part 2. Coagulation Issues Across all Patient Spectrums -- Congenital Coagulation Disorders -- Acquired Coagulation Disorders -- Regulation and Dysregulation of Fibrinolysis -- Risks Associated with Administration of Allogeneic Blood Components -- Common Coagulation Disorders That May Arise Intraoperatively -- Evaluation and Management of Untoward Intraoperative Bleeding -- Treatment of Disseminated Intravascular Coagulation (DIC) -- Heparin-Induced Thrombocytopenia (HIT) -- Anticoagulation in Cardiovascular Diseases -- Workup and Treatment of Pulmonary Embolus -- Part 3. Coagulation Issues Specific to Neurosurgery -- Classes of Drugs and Blood Products for Acute Reversal of Anticoagulant Effect -- Rescue Strategies to Facilitate Emergency Neurosurgery in Patients on Antiplatelet or Anticoagulant Agents -- Considerations for Coagulation in the Multi‐Trauma Patient -- Cerebral Venous Sinus Thrombosis -- Coagulation Studies in Preoperative Neurosurgery Patients -- Safe Strategies for Gradual Suspension and Re-institution of Anticoagulation to Permit Elective Surgery -- Spontaneous Intracerebral Hemorrhage due to Coagulation Disorders -- Prophylactic Screening for Venous Thromboembolism in Neurosurgical Patients -- Venous Thromboembolism Prophylaxis in Neurosurgery -- Can Patients with Known Intracranial and Intraspinal Vascular Lesions be Anticoagulated? -- Intrathecal Access and Devices in Patients on Antiplatelet or Anticoagulant Therapy -- Is it Safe to Shunt Anti-coagulated NPH Patients? -- Surgical Hemostasis in the Era of Anticoagulation: Guidelines and Recommendations Summary. |
Record Nr. | UNINA-9910254554403321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Anästhesie und Intensivmedizin für die Fachpflege / / von Reinhard Larsen |
Autore | Larsen Reinhard |
Edizione | [9th ed. 2016.] |
Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2016 |
Descrizione fisica | 1 online resource (XI, 1023 S. 278 Abb., 276 Abb. in Farbe.) |
Disciplina | 610.73 |
Soggetto topico |
Nursing
Critical care medicine Anesthesiology Intensive / Critical Care Medicine |
ISBN | 3-662-50444-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | ger |
Nota di contenuto | I Grundlagen und Verfahren in der Anästhesie und Anästhesiepflege -- II Spezielle Anästhesie -- III Postoperative Versorgung -- IV Grundlagen der Intensivmedizin und Intensivpflege -- V Herz-Kreislauf-Funktion und ihre Störungen -- VI Lunge, Atmung und Beatmung -- VII Niere, Wasser-Elektrolyt- und Säure-Basen-Haushalt -- VIII Spezielle Intensivmedizin -- IX Intensivpflichtige Krankheitsbilder -- Serviceteil. |
Record Nr. | UNINA-9910483776803321 |
Larsen Reinhard
![]() |
||
Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Anästhesie und Intensivmedizin in der Herz-, Thorax- und Gefäßchirurgie / / von Reinhard Larsen |
Autore | Larsen Reinhard |
Edizione | [9th ed. 2017.] |
Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2017 |
Descrizione fisica | 1 online resource (X, 457 S. 82 Abb. in Farbe.) |
Disciplina | 617.96 |
Soggetto topico |
Anesthesiology
Critical care medicine Cardiac surgery Vascular surgery Intensive / Critical Care Medicine Cardiac Surgery Vascular Surgery |
ISBN | 3-662-52987-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | ger |
Nota di contenuto | Kardiovaskuläre Medikamente -- Überwachung der Herz-Kreislauf-Funktion -- Herz-Lungen-Maschine: Aufbau und Funktion -- Herz-Lungen-Maschine: Anästhesiemanagement -- Aortokoronare Bypassoperation -- Herzklappenoperationen -- Herztransplantation. Intensivbehandlung nach Herzoperationen. Kongenitale Herzfehler: Anästhesie und Intensivbehandlung -- Herzschrittmacher, Kardioverter/Defibrillator, Katheterablation. Lungenoperationen, Bronchoskopie, Tracheaoperationen -- Thorakale Aortenaneurysmen -- Bauchaortenaneurysma- und periphere Gefäßoperationen -- Karotisstenosenoperationen. |
Record Nr. | UNINA-9910153457903321 |
Larsen Reinhard
![]() |
||
Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|